187 results
Page 7 of 10
POS AM
kdnwa
26 Mar 21
Prospectus update (post-effective amendment)
12:00am
8-K
EX-99.1
dcrtrsb 64lw
25 Mar 21
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
12:00am
8-K
EX-99.2
2unjm4k gbtouo
10 Feb 21
Regulation FD Disclosure
8:45am
8-K
EX-99.1
b9yw172 uwfv
10 Feb 21
Regulation FD Disclosure
8:45am
8-K
EX-99.1
425dy980riwjvflk
8 Dec 20
Regulation FD Disclosure
8:01am
8-K
EX-3.2
gxel mh4oe91c2
2 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:55pm
8-K
EX-99.1
0hsbjrozqbnn1i9v2
2 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:55pm
8-K
EX-99.1
spn4v
12 Nov 20
Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results
4:11pm
8-K
EX-99.1
6kpgeroypm4245
14 Sep 20
Regulation FD Disclosure
8:00am
8-K
EX-99.2
ts8p4v2zuxwf2qm9
1 Sep 20
Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:12pm
8-K
EX-99.1
q1godg8
1 Sep 20
Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:12pm
8-K
EX-1.1
akq74o
1 Sep 20
Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:12pm
424B4
hgw5pgx
28 Aug 20
Prospectus supplement with pricing info
9:42pm